Their reduced density can reflect underlying changes in maturation, activation, and granule composition rather than a single uniform cell state. Consequently, the low-density fraction may include immature cells alongside activated cells with different functional properties. Recognizing these sources of variation helps cancer researchers avoid treating every cell in the fraction as biologically equivalent.
Many cells in this population show immunosuppressive activity through mechanisms involving reactive oxygen species and arginase-1, together with direct or indirect interactions with T cells. These mechanisms can alter the immune environment surrounding a tumor by limiting effective T-cell responses. Their presence therefore provides functional context beyond simply measuring neutrophil abundance.
Separating this fraction from conventional high-density neutrophils can reveal tumor-associated states that may be missed when all neutrophils are analyzed together. The distinction is important because low-density cells can contain immature or activated subsets with potentially different effects on immunity. Comparisons between fractions may therefore clarify which neutrophil states are linked to tumor-promoting activity.
Researchers use density-gradient centrifugation to separate peripheral blood cells according to density, then examine the fraction that separates with peripheral blood mononuclear cells rather than with conventional high-density neutrophils. The high-density fraction provides a useful comparison during interpretation. Because the low-density compartment is heterogeneous, its findings should be evaluated as a mixed population rather than a single defined subtype.
Analysis of this population can help characterize the tumor-associated immune environment and examine relationships with disease progression. Researchers can also assess whether changes in the fraction correspond with treatment response. These applications make the population useful for studying how altered neutrophil states relate to cancer behavior and to variation in immune conditions.
Heterogeneity is the central limitation. The fraction may contain cells at different maturation and activation states, with variation in granule composition and immunosuppressive behavior. A measured change may therefore reflect shifts in cellular composition rather than one consistent biological program. Careful interpretation is essential before using the population as a biomarker or selecting it as a therapeutic target.